» Articles » PMID: 20224562

The Generation of Hepatocytes from Mesenchymal Stem Cells and Engraftment into Murine Liver

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2010 Mar 13
PMID 20224562
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Donor organ shortage is still the major obstacle for the clinical application of hepatocyte transplantation in the treatment of liver diseases. However, generation of hepatocyte-like cells from mesenchymal stem cells (MSCs) has become a real alternative to the isolation of primary hepatocytes. MSCs are extracted from the tissue by collagenase digestion and enriched by their capacity to grow on plastic surfaces. Enriched cells display distinct mesenchymal surface markers and are capable of multiple lineage differentiation. In the presence of specific growth conditions, the cells adopt functional features of differentiated hepatocytes. After orthotopic transplantation, differentiated human stem cells engraft in the host liver parenchyma of immunocompromised mice. This protocol describes the in vitro differentiation of stem cells from human bone marrow and their transplantation into livers of immunodeficient mice. The cell culture procedures take about 4-5 weeks, and cells engrafted in the mouse liver may be detected 2-3 months after transplantation.

Citing Articles

The Differentiation and Regeneration Potential of ABCB5 Mesenchymal Stem Cells: A Review and Clinical Perspectives.

He Z, Starkuviene V, Keese M J Clin Med. 2025; 14(3).

PMID: 39941329 PMC: 11818130. DOI: 10.3390/jcm14030660.


Fasudil and viscosity of gelatin promote hepatic differentiation by regulating organelles in human umbilical cord matrix-mesenchymal stem cells.

Choi J, Kang S, An H, Kim C, Lee S, Pack C Stem Cell Res Ther. 2024; 15(1):229.

PMID: 39075621 PMC: 11288082. DOI: 10.1186/s13287-024-03851-9.


Approaching Thrombospondin-1 as a Potential Target for Mesenchymal Stromal Cells to Support Liver Regeneration after Partial Hepatectomy in Mouse and Humans.

Tietze L, Christ M, Yu J, Stock P, Nickel S, Schulze A Cells. 2024; 13(6.

PMID: 38534373 PMC: 10969617. DOI: 10.3390/cells13060529.


Trends of regenerative tissue engineering for oral and maxillofacial reconstruction in veterinary medicine.

Purbantoro S, Taephatthanasagon T, Purwaningrum M, Hirankanokchot T, Peralta S, Fiani N Front Vet Sci. 2024; 11:1325559.

PMID: 38450027 PMC: 10915013. DOI: 10.3389/fvets.2024.1325559.


Therapeutic and Safety Promise of Mesenchymal Stem Cells for Liver Failure: From Preclinical Experiment to Clinical Application.

Xie Q, Gu J Curr Stem Cell Res Ther. 2023; 19(10):1351-1368.

PMID: 37807649 DOI: 10.2174/011574888X260690230921174343.


References
1.
Hong S, Gang E, Jeong J, Ahn C, Hwang S, Yang I . In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun. 2005; 330(4):1153-61. DOI: 10.1016/j.bbrc.2005.03.086. View

2.
Sokal E, Smets F, Bourgois A, Van Maldergem L, Buts J, Reding R . Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation. 2003; 76(4):735-8. DOI: 10.1097/01.TP.0000077420.81365.53. View

3.
Phinney D, Prockop D . Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007; 25(11):2896-902. DOI: 10.1634/stemcells.2007-0637. View

4.
Collas P, Noer A, Timoskainen S . Programming the genome in embryonic and somatic stem cells. J Cell Mol Med. 2007; 11(4):602-20. PMC: 3823245. DOI: 10.1111/j.1582-4934.2007.00079.x. View

5.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View